[[abstract]]Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were evaluated as P1-residues in dipeptide-derived inhibitors of DPP8/9. Potency testing indicates that DPP8 or DPP9 specificity cannot be obtained with the selected set of P1- and P2-fragments. Nonetheless, the nanomolar DPP8/9 potencies and remarkable selectivities with respect to DPP IV and DPPII, makes inhibitors 4c and 4h suitable "leads" for future inhibitor optimization effort
[[abstract]]A series of 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-...
BACKGROUND: There has been great interest in determining whether natural products show biological ac...
AbstractDipeptidyl peptidase 4 (DPP4) is recognised as an attractive anti-diabetic drug target, and ...
[[abstract]]Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were...
[[abstract]]Dipeptide derivatives bearing various P2 residues and pyrrolidine derivatives as P1 mimi...
[[abstract]]This work represents the first directed study to identify modification points in the top...
[[abstract]]To obtain selective and potent inhibitors of dipeptidyl peptidases 8 and 9, we synthesiz...
[[abstract]]To find potent and selective inhibitors of dipeptidyl peptidase IV (DPP-IV), we synthesi...
Abstract: Vildagliptin is a marketed DPP4 inhibitor, used in the management of type 2 diabetes. The ...
[[abstract]]Dipeptide-derived compounds, bearing various P2 residues and a diaryl pyrrolidin-2-yl ph...
[[abstract]]DPP8 is a prolyl dipeptidase homologous to DPP-IV, which is a drug target for Type 11 di...
[[abstract]]A series of (2S)-cyanopyrrolidines with glutamic acid derivatives at the P2 site have be...
Abstract: Dipeptidyl peptidase 9 (DPP9) is a proline-selective serine protease that plays a key role...
to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV...
[[abstract]]Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a new type of antidia...
[[abstract]]A series of 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-...
BACKGROUND: There has been great interest in determining whether natural products show biological ac...
AbstractDipeptidyl peptidase 4 (DPP4) is recognised as an attractive anti-diabetic drug target, and ...
[[abstract]]Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were...
[[abstract]]Dipeptide derivatives bearing various P2 residues and pyrrolidine derivatives as P1 mimi...
[[abstract]]This work represents the first directed study to identify modification points in the top...
[[abstract]]To obtain selective and potent inhibitors of dipeptidyl peptidases 8 and 9, we synthesiz...
[[abstract]]To find potent and selective inhibitors of dipeptidyl peptidase IV (DPP-IV), we synthesi...
Abstract: Vildagliptin is a marketed DPP4 inhibitor, used in the management of type 2 diabetes. The ...
[[abstract]]Dipeptide-derived compounds, bearing various P2 residues and a diaryl pyrrolidin-2-yl ph...
[[abstract]]DPP8 is a prolyl dipeptidase homologous to DPP-IV, which is a drug target for Type 11 di...
[[abstract]]A series of (2S)-cyanopyrrolidines with glutamic acid derivatives at the P2 site have be...
Abstract: Dipeptidyl peptidase 9 (DPP9) is a proline-selective serine protease that plays a key role...
to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV...
[[abstract]]Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a new type of antidia...
[[abstract]]A series of 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-...
BACKGROUND: There has been great interest in determining whether natural products show biological ac...
AbstractDipeptidyl peptidase 4 (DPP4) is recognised as an attractive anti-diabetic drug target, and ...